Skip to content

Placental Weight in Infants of Gestational Diabetic Mothers

Placental Weight and Placental Weight-to-Birth Weight Ratio as Predictors of Early Neonatal Glycemic Profiles in Infants Born to Mothers With Gestational Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07765784
Enrollment
98
Registered
2026-08-14
Start date
2025-04-01
Completion date
2026-01-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoglycaemia, Infants of Diabetic Mothers, Placenta

Brief summary

This prospective cross-sectional study examined the relationship between placental weight and early neonatal outcomes, such as blood glucose levels within the first 24 hours and early neonatal morbidities in infants born to mothers with gestational diabetes. levels in the first 24 hours of life and early neonatal morbidities, in infants born to mothers with gestational diabetes.

Detailed description

This prospective cross-sectional study investigated the association between placental weight and early neonatal outcomes, including blood glucose levels within the first 24 hours and early neonatal morbidities in infants born to mothers with gestational diabetes.

Interventions

DIAGNOSTIC_TESTBlood Glucose Level

Blood glucose levels of the infants enrolled in the study were checked at the first 30 minutes after birth and at the end of 1,2, 6,24 hours of life.

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 2 Days
Healthy volunteers
No

Inclusion criteria

* Infants born at the study center * a gestational age of ≥35 weeks * singleton pregnancies * maternal ages between 18 and 35 years

Exclusion criteria

* preterm birth (\<35 weeks of gestation) * referral to another center after delivery * presence of chromosomal and/or congenital anomalies * maternal conditions other than gestational diabetes * lack of parental consent

Design outcomes

Primary

MeasureTime frameDescription
Hypoglycemia8 monthsIf the infants had a blood glucose level below the predefined limits, they would be included in the hypoglycemia group.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026